Evaluation of the Financial Performances of the Medical Device Companies among Fortune 500 Companies before, during and after the COVID-19 Pandemic
- 6 January 2025
- journal article
- Published by Mİnistry of Health, GD Health Services, HTA Department in Eurasian Journal of Health Technology Assessment
- Vol. 8 (2) , 72-83
Abstract
Purpose: The purpose of this study was to evaluate the financial performances of the six medical device companies among Fortune 500 companies before, during and after the COVID-19 pandemic. Methodology: We first conducted ratio analysis by using liquidity, turnover, leverage and profitability ratios; then we conducted Wilcoxon signed-rank tests by using the calculated values of the financial ratios. We obtained the required data from the annual financial statements of the medical device companies among Fortune 500 companies. In the analyses, we took 2019 as the year before the COVID-19 pandemic, 2020 and 2021 as the year of the COVID-19 pandemic and 2022 as the year after the COVID-19 pandemic. Results: The results of the study showed that the medical device companies among Fortune 500 companies were able to keep their financial performances steady when the COVID-19 pandemic began; they were able to increase their profits in the second year of the COVID-19 pandemic; and they were able to start using their assets more efficiently after the COVID-19 pandemic. Discussion: The findings of the study suggests that the overall financial performances of the medical device companies among Fortune 500 companies were strong before, during and after the COVID-19 pandemic. The evaluation of the financial performances of the medical device companies among Fortune 500 companies before, during and after the COVID-19 pandemic may be beneficial for managers and policy makers in the medical device industry to determine the areas that requires to be strengthened in order to be better prepared for possible future pandemics and crisis periods.Keywords
All Related Versions
This publication has 19 references indexed in Scilit:
- Changes in US Hospital Financial Performance During the COVID-19 Public Health EmergencyJAMA Health Forum, 2023
- Covid-19 triage in the emergency department 2.0: how analytics and AI transform a human-made algorithm for the prediction of clinical pathwaysHealth Care Management Science, 2023
- Medical device companies crisis communication response to stakeholders during COVID-19: pre-crisis stage to new normalInternational Journal of Pharmaceutical and Healthcare Marketing, 2023
- Demand and Supply Disruptions During the Covid-19 Crisis on Firm ProductivityGlobal Journal of Flexible Systems Management, 2022
- The impact of COVID-19 on hospitals’ financial performance: Evidence from California hospitalsInternational Journal of Healthcare Management, 2022
- Improving resilience of the healthcare supply chain in a pandemic: Evidence from Europe during the COVID-19 crisisJournal of Purchasing and Supply Management, 2022
- Economic impact of COVID-19 pandemic on healthcare facilities and systems: International perspectivesBest Practice & Research Clinical Anaesthesiology, 2021
- Financial performance of China’s listed firms in presence of coronavirus: Evidence from corporate culture and corporate social responsibilityCurrent Psychology, 2021
- COVID-19: ensuring our medical equipment can meet the challengeExpert Review of Medical Devices, 2020
- Towards Stronger EU Governance of Health Threats after the COVID-19 PandemicEuropean Journal of Risk Regulation, 2020